Femasys receives Nasdaq delisting notice for MVLS below $35M; 180-day cure period until Nov 2025

FEMASYS INC

Nasdaq notified Femasys MVLS of common stock was below $35M minimum for 30 consecutive business days.
Femasys also fails alternative listing standards: stockholders' equity <$2.5M or net income <$500k.
Company has 180 calendar days, until November 17, 2025, to regain compliance.
No immediate effect on listing; Femasys will monitor MVLS and consider options to regain compliance.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.